GoldBamboo.com - Knowledge is strong medicine
  

Study of Zoledronic Acid for Patients With Hormone-Sensitive Bone Metastases From Prostate Cancer - Article


  Not Signed In - Sign In / Register




General Topics A-Z

Gamma-Linolenic Acid (GLA)

Clinical Trial: Study of Zoledronic Acid for Patients With Hormone-Sensitive Bone Metastases From Prostate Cancer

This study is not yet open for patient recruitment.
Verified by Novartis October 2005

Sponsored by: Novartis
Information provided by: Novartis
ClinicalTrials.gov Identifier: NCT00242567

Purpose

This study aims to determine whether early treatment with zoledronic acid, that is given during the early phase of advanced prostate cancer, will be more efficacious than delayed treatment
Condition Intervention Phase
Prostate Cancer
  Drug: Zoledronic Acid
 Phase III

MedlinePlus related topics:  Prostate Cancer

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Further study details as provided by Novartis:

Study start: October 2005

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Male
Criteria

Inclusion Criteria:

  • prostate cancer
  • at least one bone metastasis
  • receiving or about to receive androgen deprivation therapy (ADT)

Exclusion Criteria:

  • previous ADT failure
  • previous or current treatment with another bone-protecting agent, chemotherapy or targeted therapy
  • abnormal renal function

Other protocol-defined inclusion/exclusion criteria may apply.

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00242567

Novartis      +41 61 324 1111 

Australia
      multiple locations,  Australia

Brazil
      multiple locations,  Brazil

China
      multiple locations,  China

New Zealand
      multiple locations,  New Zealand

Taiwan
      multiple locations,  Taiwan

Thailand
      multiple locations,  Thailand

Study chairs or principal investigators

Novartis,  Study Chair,  Novartis   

More Information

Study ID Numbers:  CZOL446E2432
Last Updated:  December 8, 2005
Record first received:  October 19, 2005
ClinicalTrials.gov Identifier:  NCT00242567
Health Authority: Thailand: Food and Drug Administration
ClinicalTrials.gov processed this record on 2006-01-10


Source: ClinicalTrials.gov
Cache Date: January 11, 2006


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Gamma-Linolenic Acid (GLA).

September 8, 2008


Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.